Study protocol for the randomised controlled trial: combined multimarker screening and randomised patient treatment with ASpirin for evidence-based PREeclampsia prevention (ASPRE)

INTRODUCTION: Pre-eclampsia (PE) affects 2–3% of all pregnancies and is a major cause of maternal and perinatal morbidity and mortality. Prophylactic use of low-dose aspirin in women at risk for PE may substantially reduce the prevalence of the disease. Effective screening for PE requiring delivery...

Descripción completa

Detalles Bibliográficos
Autores principales: O'Gorman, Neil, Wright, David, Rolnik, Daniel L, Nicolaides, Kypros H, Poon, Liona C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Evidence Based Practice
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4932292/
https://www.ncbi.nlm.nih.gov/pubmed/27354081
http://dx.doi.org/10.1136/bmjopen-2016-011801

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4932292/
https://www.ncbi.nlm.nih.gov/pubmed/27354081
http://dx.doi.org/10.1136/bmjopen-2016-011801

Ejemplares similares